$RPTP Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in HORIZON PHARMACEUTICAL LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in HORIZON PHARMACEUTICAL LLC. Get notifications about new insider transactions in HORIZON PHARMACEUTICAL LLC for free.
Page: < prev 1 ... 2 3 4 5 6 7 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 17 2012 | RPTP | Raptor Pharmaceuti ... | Tsuchimoto Kim R | Chief Financial Off ... | Sell | S | 6.05 | 3,559 | 21,532 | 582 | 4.1 K to 582 (-85.95 %) |
| Apr 17 2012 | RPTP | Raptor Pharmaceuti ... | Tsuchimoto Kim R | Chief Financial Off ... | Buy | M | 2.57 | 3,559 | 9,147 | 4,141 | 582 to 4.1 K (+611.51 %) |
| Apr 13 2012 | RPTP | Raptor Pharmaceuti ... | RIOUX PATRICE | Option Exercise | M | 0.85 | 25,497 | 21,672 | 354,696 | ||
| Apr 13 2012 | RPTP | Raptor Pharmaceuti ... | RIOUX PATRICE | Buy | M | 0.85 | 25,497 | 21,672 | 25,497 | 0 to 25.5 K | |
| Apr 05 2012 | RPTP | Raptor Pharmaceuti ... | SAGER ERICH | Director | Option Exercise | M | 2.57 | 10,986 | 28,234 | 522,423 | |
| Apr 05 2012 | RPTP | Raptor Pharmaceuti ... | SAGER ERICH | Director | Sell | S | 6.80 | 600 | 4,080 | 507,512 | 508.1 K to 507.5 K (-0.12 %) |
| Apr 05 2012 | RPTP | Raptor Pharmaceuti ... | SAGER ERICH | Director | Sell | S | 6.79 | 886 | 6,016 | 508,112 | 509 K to 508.1 K (-0.17 %) |
| Apr 05 2012 | RPTP | Raptor Pharmaceuti ... | SAGER ERICH | Director | Sell | S | 6.78 | 902 | 6,116 | 508,998 | 509.9 K to 509 K (-0.18 %) |
| Apr 05 2012 | RPTP | Raptor Pharmaceuti ... | SAGER ERICH | Director | Sell | S | 6.78 | 100 | 678 | 509,900 | 510 K to 509.9 K (-0.02 %) |
| Apr 05 2012 | RPTP | Raptor Pharmaceuti ... | SAGER ERICH | Director | Sell | S | 6.77 | 800 | 5,416 | 510,000 | 510.8 K to 510 K (-0.16 %) |
| Apr 05 2012 | RPTP | Raptor Pharmaceuti ... | SAGER ERICH | Director | Sell | S | 6.76 | 200 | 1,352 | 510,800 | 511 K to 510.8 K (-0.04 %) |
| Apr 05 2012 | RPTP | Raptor Pharmaceuti ... | SAGER ERICH | Director | Sell | S | 6.76 | 100 | 676 | 511,000 | 511.1 K to 511 K (-0.02 %) |
| Apr 05 2012 | RPTP | Raptor Pharmaceuti ... | SAGER ERICH | Director | Sell | S | 6.75 | 423 | 2,855 | 511,100 | 511.5 K to 511.1 K (-0.08 %) |
| Apr 05 2012 | RPTP | Raptor Pharmaceuti ... | SAGER ERICH | Director | Sell | S | 6.75 | 100 | 675 | 511,523 | 511.6 K to 511.5 K (-0.02 %) |
| Apr 05 2012 | RPTP | Raptor Pharmaceuti ... | SAGER ERICH | Director | Sell | S | 6.74 | 900 | 6,066 | 511,623 | 512.5 K to 511.6 K (-0.18 %) |
| Apr 05 2012 | RPTP | Raptor Pharmaceuti ... | SAGER ERICH | Director | Sell | S | 6.73 | 600 | 4,038 | 512,523 | 513.1 K to 512.5 K (-0.12 %) |
| Apr 05 2012 | RPTP | Raptor Pharmaceuti ... | SAGER ERICH | Director | Sell | S | 6.72 | 2,100 | 14,112 | 513,123 | 515.2 K to 513.1 K (-0.41 %) |
| Apr 05 2012 | RPTP | Raptor Pharmaceuti ... | SAGER ERICH | Director | Sell | S | 6.71 | 1,100 | 7,381 | 515,223 | 516.3 K to 515.2 K (-0.21 %) |
| Apr 05 2012 | RPTP | Raptor Pharmaceuti ... | SAGER ERICH | Director | Sell | S | 6.71 | 100 | 671 | 516,323 | 516.4 K to 516.3 K (-0.02 %) |
| Apr 05 2012 | RPTP | Raptor Pharmaceuti ... | SAGER ERICH | Director | Sell | S | 6.70 | 4,409 | 29,540 | 516,423 | 520.8 K to 516.4 K (-0.85 %) |
| Apr 05 2012 | RPTP | Raptor Pharmaceuti ... | SAGER ERICH | Director | Sell | S | 6.69 | 1,200 | 8,028 | 520,832 | 522 K to 520.8 K (-0.23 %) |
| Apr 05 2012 | RPTP | Raptor Pharmaceuti ... | SAGER ERICH | Director | Sell | S | 6.66 | 391 | 2,604 | 522,032 | 522.4 K to 522 K (-0.07 %) |
| Apr 05 2012 | RPTP | Raptor Pharmaceuti ... | SAGER ERICH | Director | Buy | M | 2.57 | 10,986 | 28,234 | 522,423 | 511.4 K to 522.4 K (+2.15 %) |
| Apr 04 2012 | RPTP | Raptor Pharmaceuti ... | STARR CHRISTOPHER M | Chief Executive Off ... | Option Exercise | M | 2.83 | 10,085 | 28,541 | 1,082,673 | |
| Apr 04 2012 | RPTP | Raptor Pharmaceuti ... | STARR CHRISTOPHER M | Chief Executive Off ... | Sell | S | 6.82 | 100 | 682 | 1,082,673 | 1.1 M to 1.1 M (-0.01 %) |
| Apr 04 2012 | RPTP | Raptor Pharmaceuti ... | STARR CHRISTOPHER M | Chief Executive Off ... | Sell | S | 6.80 | 200 | 1,360 | 1,082,773 | 1.1 M to 1.1 M (-0.02 %) |
| Apr 04 2012 | RPTP | Raptor Pharmaceuti ... | STARR CHRISTOPHER M | Chief Executive Off ... | Sell | S | 6.80 | 200 | 1,359 | 1,082,973 | 1.1 M to 1.1 M (-0.02 %) |
| Apr 04 2012 | RPTP | Raptor Pharmaceuti ... | STARR CHRISTOPHER M | Chief Executive Off ... | Sell | S | 6.79 | 185 | 1,256 | 1,083,173 | 1.1 M to 1.1 M (-0.02 %) |
| Apr 04 2012 | RPTP | Raptor Pharmaceuti ... | STARR CHRISTOPHER M | Chief Executive Off ... | Sell | S | 6.78 | 1,200 | 8,136 | 1,083,358 | 1.1 M to 1.1 M (-0.11 %) |
| Apr 04 2012 | RPTP | Raptor Pharmaceuti ... | STARR CHRISTOPHER M | Chief Executive Off ... | Sell | S | 6.77 | 600 | 4,062 | 1,084,558 | 1.1 M to 1.1 M (-0.06 %) |
| Apr 04 2012 | RPTP | Raptor Pharmaceuti ... | STARR CHRISTOPHER M | Chief Executive Off ... | Sell | S | 6.75 | 100 | 675 | 1,085,158 | 1.1 M to 1.1 M (-0.01 %) |
| Apr 04 2012 | RPTP | Raptor Pharmaceuti ... | STARR CHRISTOPHER M | Chief Executive Off ... | Sell | S | 6.75 | 100 | 675 | 1,085,258 | 1.1 M to 1.1 M (-0.01 %) |
| Apr 04 2012 | RPTP | Raptor Pharmaceuti ... | STARR CHRISTOPHER M | Chief Executive Off ... | Sell | S | 6.74 | 500 | 3,370 | 1,085,358 | 1.1 M to 1.1 M (-0.05 %) |
| Apr 04 2012 | RPTP | Raptor Pharmaceuti ... | STARR CHRISTOPHER M | Chief Executive Off ... | Sell | S | 6.73 | 500 | 3,365 | 1,085,858 | 1.1 M to 1.1 M (-0.05 %) |
| Apr 04 2012 | RPTP | Raptor Pharmaceuti ... | STARR CHRISTOPHER M | Chief Executive Off ... | Sell | S | 6.72 | 800 | 5,376 | 1,086,358 | 1.1 M to 1.1 M (-0.07 %) |
| Apr 04 2012 | RPTP | Raptor Pharmaceuti ... | STARR CHRISTOPHER M | Chief Executive Off ... | Sell | S | 6.71 | 400 | 2,684 | 1,087,158 | 1.1 M to 1.1 M (-0.04 %) |
| Apr 04 2012 | RPTP | Raptor Pharmaceuti ... | STARR CHRISTOPHER M | Chief Executive Off ... | Sell | S | 6.70 | 3,400 | 22,780 | 1,087,558 | 1.1 M to 1.1 M (-0.31 %) |
| Apr 04 2012 | RPTP | Raptor Pharmaceuti ... | STARR CHRISTOPHER M | Chief Executive Off ... | Sell | S | 6.69 | 900 | 6,021 | 1,090,958 | 1.1 M to 1.1 M (-0.08 %) |
| Apr 04 2012 | RPTP | Raptor Pharmaceuti ... | STARR CHRISTOPHER M | Chief Executive Off ... | Sell | S | 6.68 | 600 | 4,008 | 1,091,858 | 1.1 M to 1.1 M (-0.05 %) |
| Apr 04 2012 | RPTP | Raptor Pharmaceuti ... | STARR CHRISTOPHER M | Chief Executive Off ... | Sell | S | 6.66 | 300 | 1,998 | 1,092,458 | 1.1 M to 1.1 M (-0.03 %) |
| Apr 04 2012 | RPTP | Raptor Pharmaceuti ... | STARR CHRISTOPHER M | Chief Executive Off ... | Buy | M | 2.83 | 10,085 | 28,541 | 1,092,758 | 1.1 M to 1.1 M (+0.93 %) |
| Apr 04 2012 | RPTP | Raptor Pharmaceuti ... | Anderson Raymond | Director | Option Exercise | M | 2.57 | 6,128 | 15,749 | 388,747 | |
| Apr 04 2012 | RPTP | Raptor Pharmaceuti ... | Anderson Raymond | Director | Sell | S | 6.76 | 1,700 | 11,492 | 388,747 | 390.4 K to 388.7 K (-0.44 %) |
| Apr 04 2012 | RPTP | Raptor Pharmaceuti ... | Anderson Raymond | Director | Sell | S | 6.74 | 200 | 1,348 | 390,447 | 390.6 K to 390.4 K (-0.05 %) |
| Apr 04 2012 | RPTP | Raptor Pharmaceuti ... | Anderson Raymond | Director | Sell | S | 6.73 | 500 | 3,365 | 390,647 | 391.1 K to 390.6 K (-0.13 %) |
| Apr 04 2012 | RPTP | Raptor Pharmaceuti ... | Anderson Raymond | Director | Sell | S | 6.72 | 500 | 3,360 | 391,147 | 391.6 K to 391.1 K (-0.13 %) |
| Apr 04 2012 | RPTP | Raptor Pharmaceuti ... | Anderson Raymond | Director | Sell | S | 6.71 | 200 | 1,342 | 391,647 | 391.8 K to 391.6 K (-0.05 %) |
| Apr 04 2012 | RPTP | Raptor Pharmaceuti ... | Anderson Raymond | Director | Sell | S | 6.70 | 1,600 | 10,720 | 391,847 | 393.4 K to 391.8 K (-0.41 %) |
| Apr 04 2012 | RPTP | Raptor Pharmaceuti ... | Anderson Raymond | Director | Sell | S | 6.70 | 1,428 | 9,568 | 393,447 | 394.9 K to 393.4 K (-0.36 %) |
| Apr 04 2012 | RPTP | Raptor Pharmaceuti ... | Anderson Raymond | Director | Buy | M | 2.57 | 6,128 | 15,749 | 394,875 | 388.7 K to 394.9 K (+1.58 %) |
| Mar 16 2012 | RPTP | Raptor Pharmaceuti ... | Keltner Llew | Director | Option Exercise | M | 3.30 | 967 | 3,191 | 288,034 | |
| Mar 16 2012 | RPTP | Raptor Pharmaceuti ... | Keltner Llew | Director | Sell | S | 6.99 | 967 | 6,759 | 0 | 967 to 0 (-100.00 %) |
| Mar 16 2012 | RPTP | Raptor Pharmaceuti ... | Keltner Llew | Director | Buy | M | 3.30 | 967 | 3,191 | 967 | 0 to 967 |
| Mar 01 2012 | RPTP | Raptor Pharmaceuti ... | Anderson Raymond | Director | Option Exercise | M | 2.57 | 6,128 | 15,749 | 388,747 | |
| Mar 01 2012 | RPTP | Raptor Pharmaceuti ... | Anderson Raymond | Director | Sell | S | 7.29 | 6,128 | 44,673 | 0 | 6.1 K to 0 (-100.00 %) |
| Mar 01 2012 | RPTP | Raptor Pharmaceuti ... | Anderson Raymond | Director | Buy | M | 2.57 | 6,128 | 15,749 | 6,128 | 0 to 6.1 K |
| Feb 16 2012 | RPTP | Raptor Pharmaceuti ... | Daley Thomas E | Sell | S | 7.74 | 3,333 | 25,797 | 101,571 | 104.9 K to 101.6 K (-3.18 %) | |
| Feb 16 2012 | RPTP | Raptor Pharmaceuti ... | Tsuchimoto Kim R | Chief Financial Off ... | Option Exercise | M | 2.57 | 3,559 | 9,147 | 413,602 | |
| Feb 16 2012 | RPTP | Raptor Pharmaceuti ... | Tsuchimoto Kim R | Chief Financial Off ... | Sell | S | 7.74 | 3,559 | 27,547 | 582 | 4.1 K to 582 (-85.95 %) |
| Feb 16 2012 | RPTP | Raptor Pharmaceuti ... | Tsuchimoto Kim R | Chief Financial Off ... | Buy | M | 2.57 | 3,559 | 9,147 | 4,141 | 582 to 4.1 K (+611.51 %) |
| Feb 16 2012 | RPTP | Raptor Pharmaceuti ... | Keltner Llew | Director | Option Exercise | M | 3.30 | 967 | 3,191 | 289,001 | |
| Feb 16 2012 | RPTP | Raptor Pharmaceuti ... | Keltner Llew | Director | Sell | S | 7.74 | 967 | 7,485 | 0 | 967 to 0 (-100.00 %) |
| Feb 16 2012 | RPTP | Raptor Pharmaceuti ... | Keltner Llew | Director | Buy | M | 3.30 | 967 | 3,191 | 967 | 0 to 967 |
| Feb 10 2012 | RPTP | Raptor Pharmaceuti ... | Zankel Todd | Chief Scientific Of ... | Option Exercise | M | 2.02 | 287 | 580 | 316,779 | |
| Feb 10 2012 | RPTP | Raptor Pharmaceuti ... | Zankel Todd | Chief Scientific Of ... | Option Exercise | M | 2.83 | 3,643 | 10,310 | 317,066 | |
| Feb 10 2012 | RPTP | Raptor Pharmaceuti ... | Zankel Todd | Chief Scientific Of ... | Sell | S | 7.67 | 287 | 2,201 | 686,834 | 687.1 K to 686.8 K (-0.04 %) |
| Feb 10 2012 | RPTP | Raptor Pharmaceuti ... | Zankel Todd | Chief Scientific Of ... | Sell | S | 7.84 | 100 | 784 | 687,121 | 687.2 K to 687.1 K (-0.01 %) |
| Feb 10 2012 | RPTP | Raptor Pharmaceuti ... | Zankel Todd | Chief Scientific Of ... | Sell | S | 7.84 | 2,100 | 16,454 | 687,221 | 689.3 K to 687.2 K (-0.30 %) |
| Feb 10 2012 | RPTP | Raptor Pharmaceuti ... | Zankel Todd | Chief Scientific Of ... | Sell | S | 7.83 | 615 | 4,815 | 689,321 | 689.9 K to 689.3 K (-0.09 %) |
| Feb 10 2012 | RPTP | Raptor Pharmaceuti ... | Zankel Todd | Chief Scientific Of ... | Sell | S | 7.81 | 1,500 | 11,715 | 689,936 | 691.4 K to 689.9 K (-0.22 %) |
| Feb 10 2012 | RPTP | Raptor Pharmaceuti ... | Zankel Todd | Chief Scientific Of ... | Sell | S | 7.81 | 200 | 1,561 | 691,436 | 691.6 K to 691.4 K (-0.03 %) |
| Feb 10 2012 | RPTP | Raptor Pharmaceuti ... | Zankel Todd | Chief Scientific Of ... | Sell | S | 7.80 | 1,400 | 10,920 | 691,636 | 693 K to 691.6 K (-0.20 %) |
| Feb 10 2012 | RPTP | Raptor Pharmaceuti ... | Zankel Todd | Chief Scientific Of ... | Sell | S | 7.76 | 200 | 1,552 | 693,036 | 693.2 K to 693 K (-0.03 %) |
| Feb 10 2012 | RPTP | Raptor Pharmaceuti ... | Zankel Todd | Chief Scientific Of ... | Sell | S | 7.75 | 2,600 | 20,150 | 693,236 | 695.8 K to 693.2 K (-0.37 %) |
| Feb 10 2012 | RPTP | Raptor Pharmaceuti ... | Zankel Todd | Chief Scientific Of ... | Sell | S | 7.74 | 700 | 5,418 | 695,836 | 696.5 K to 695.8 K (-0.10 %) |
| Feb 10 2012 | RPTP | Raptor Pharmaceuti ... | Zankel Todd | Chief Scientific Of ... | Sell | S | 7.73 | 400 | 3,092 | 696,536 | 696.9 K to 696.5 K (-0.06 %) |
| Feb 10 2012 | RPTP | Raptor Pharmaceuti ... | Zankel Todd | Chief Scientific Of ... | Sell | S | 7.72 | 1,300 | 10,036 | 696,936 | 698.2 K to 696.9 K (-0.19 %) |
| Feb 10 2012 | RPTP | Raptor Pharmaceuti ... | Zankel Todd | Chief Scientific Of ... | Sell | S | 7.71 | 3,700 | 28,527 | 698,236 | 701.9 K to 698.2 K (-0.53 %) |
| Feb 10 2012 | RPTP | Raptor Pharmaceuti ... | Zankel Todd | Chief Scientific Of ... | Sell | S | 7.70 | 300 | 2,309 | 701,936 | 702.2 K to 701.9 K (-0.04 %) |
| Feb 10 2012 | RPTP | Raptor Pharmaceuti ... | Zankel Todd | Chief Scientific Of ... | Sell | S | 7.69 | 300 | 2,307 | 702,236 | 702.5 K to 702.2 K (-0.04 %) |
| Feb 10 2012 | RPTP | Raptor Pharmaceuti ... | Zankel Todd | Chief Scientific Of ... | Sell | S | 7.68 | 600 | 4,608 | 702,536 | 703.1 K to 702.5 K (-0.09 %) |
| Feb 10 2012 | RPTP | Raptor Pharmaceuti ... | Zankel Todd | Chief Scientific Of ... | Sell | S | 7.67 | 1,470 | 11,275 | 703,136 | 704.6 K to 703.1 K (-0.21 %) |
| Feb 10 2012 | RPTP | Raptor Pharmaceuti ... | Zankel Todd | Chief Scientific Of ... | Sell | S | 7.67 | 1,443 | 11,068 | 704,606 | 706 K to 704.6 K (-0.20 %) |
| Feb 10 2012 | RPTP | Raptor Pharmaceuti ... | Zankel Todd | Chief Scientific Of ... | Sell | S | 7.66 | 1,500 | 11,490 | 706,049 | 707.5 K to 706 K (-0.21 %) |
| Feb 10 2012 | RPTP | Raptor Pharmaceuti ... | Zankel Todd | Chief Scientific Of ... | Sell | S | 7.65 | 700 | 5,355 | 707,549 | 708.2 K to 707.5 K (-0.10 %) |
| Feb 10 2012 | RPTP | Raptor Pharmaceuti ... | Zankel Todd | Chief Scientific Of ... | Buy | M | 2.02 | 287 | 580 | 708,249 | 708 K to 708.2 K (+0.04 %) |
| Feb 10 2012 | RPTP | Raptor Pharmaceuti ... | Zankel Todd | Chief Scientific Of ... | Buy | M | 2.83 | 3,643 | 10,310 | 707,962 | 704.3 K to 708 K (+0.52 %) |
| Sep 26 2011 | RPTP | Raptor Pharmaceuti ... | Tsuchimoto Kim R | Chief Financial Off ... | Option Exercise | A | 5.13 | 113,616 | 582,850 | 417,161 | |
| Sep 26 2011 | RPTP | Raptor Pharmaceuti ... | Tsuchimoto Kim R | Chief Financial Off ... | Option Exercise | A | 5.13 | 37,872 | 194,283 | 303,545 | |
| Sep 26 2011 | RPTP | Raptor Pharmaceuti ... | Zankel Todd | Chief Scientific Of ... | Option Exercise | A | 5.13 | 87,345 | 448,080 | 320,709 | |
| Sep 26 2011 | RPTP | Raptor Pharmaceuti ... | Zankel Todd | Chief Scientific Of ... | Option Exercise | A | 5.13 | 29,115 | 149,360 | 233,364 | |
| Sep 26 2011 | RPTP | Raptor Pharmaceuti ... | Walbert Timothy P | Director | Option Exercise | A | 5.13 | 90,000 | 461,700 | 180,000 | |
| Sep 26 2011 | RPTP | Raptor Pharmaceuti ... | Walbert Timothy P | Director | Option Exercise | A | 5.13 | 15,000 | 76,950 | 90,000 | |
| Sep 26 2011 | RPTP | Raptor Pharmaceuti ... | STARR CHRISTOPHER M | Chief Executive Off ... | Option Exercise | A | 5.13 | 345,048 | 1,770,096 | 1,082,673 | |
| Sep 26 2011 | RPTP | Raptor Pharmaceuti ... | STARR CHRISTOPHER M | Chief Executive Off ... | Option Exercise | A | 5.13 | 115,016 | 590,032 | 737,625 | |
| Sep 26 2011 | RPTP | Raptor Pharmaceuti ... | SAMANT VIJAY B | Director | Option Exercise | A | 5.13 | 90,000 | 461,700 | 180,000 | |
| Sep 26 2011 | RPTP | Raptor Pharmaceuti ... | SAMANT VIJAY B | Director | Option Exercise | A | 5.13 | 15,000 | 76,950 | 90,000 | |
| Sep 26 2011 | RPTP | Raptor Pharmaceuti ... | SAGER ERICH | Director | Option Exercise | A | 5.13 | 90,000 | 461,700 | 511,437 | |
| Sep 26 2011 | RPTP | Raptor Pharmaceuti ... | SAGER ERICH | Director | Option Exercise | A | 5.13 | 30,000 | 153,900 | 481,437 | |
| Sep 26 2011 | RPTP | Raptor Pharmaceuti ... | RIOUX PATRICE | Option Exercise | A | 5.13 | 113,616 | 582,850 | 380,193 | ||
| Sep 26 2011 | RPTP | Raptor Pharmaceuti ... | RIOUX PATRICE | Option Exercise | A | 5.13 | 37,872 | 194,283 | 266,577 | ||
| Sep 26 2011 | RPTP | Raptor Pharmaceuti ... | Reichenberger Marc Patrick | Option Exercise | A | 5.13 | 90,000 | 461,700 | 230,000 | ||
| Sep 26 2011 | RPTP | Raptor Pharmaceuti ... | Reichenberger Marc Patrick | Option Exercise | A | 5.13 | 20,000 | 102,600 | 140,000 | ||
| Sep 26 2011 | RPTP | Raptor Pharmaceuti ... | Powell Kathlene Linn | Option Exercise | A | 5.13 | 75,000 | 384,750 | 185,417 | ||
| Sep 26 2011 | RPTP | Raptor Pharmaceuti ... | Powell Kathlene Linn | Option Exercise | A | 5.13 | 10,417 | 53,439 | 110,417 | ||
| Sep 26 2011 | RPTP | Raptor Pharmaceuti ... | Keltner Llew | Director | Option Exercise | A | 5.13 | 90,000 | 461,700 | 289,968 | |
| Sep 26 2011 | RPTP | Raptor Pharmaceuti ... | Keltner Llew | Director | Option Exercise | A | 5.13 | 30,000 | 153,900 | 199,968 | |
| Sep 26 2011 | RPTP | Raptor Pharmaceuti ... | FRANKLIN RICHARD L | Director | Option Exercise | A | 5.13 | 90,000 | 461,700 | 289,969 | |
| Sep 26 2011 | RPTP | Raptor Pharmaceuti ... | FRANKLIN RICHARD L | Director | Option Exercise | A | 5.13 | 30,000 | 153,900 | 199,969 | |
| Sep 26 2011 | RPTP | Raptor Pharmaceuti ... | Daley Thomas E | Option Exercise | A | 5.13 | 113,616 | 582,850 | 399,094 | ||
| Sep 26 2011 | RPTP | Raptor Pharmaceuti ... | Daley Thomas E | Option Exercise | A | 5.13 | 37,872 | 194,283 | 285,478 | ||
| Sep 26 2011 | RPTP | Raptor Pharmaceuti ... | Bruhn Suzanne Louise | Director | Option Exercise | A | 5.13 | 90,000 | 461,700 | 180,000 | |
| Sep 26 2011 | RPTP | Raptor Pharmaceuti ... | Bruhn Suzanne Louise | Director | Option Exercise | A | 5.13 | 15,000 | 76,950 | 90,000 | |
| Sep 26 2011 | RPTP | Raptor Pharmaceuti ... | Anderson Raymond | Director | Option Exercise | A | 5.13 | 90,000 | 461,700 | 394,875 | |
| Sep 26 2011 | RPTP | Raptor Pharmaceuti ... | Anderson Raymond | Director | Option Exercise | A | 5.13 | 30,000 | 153,900 | 304,875 | |
| Jul 26 2011 | RPTP | Raptor Pharmaceuti ... | Zankel Todd | Chief Scientific Of ... | Buy | M | 2.02 | 4,950 | 9,999 | 704,319 | 699.4 K to 704.3 K (+0.71 %) |
| Apr 13 2011 | RPTP | Raptor Pharmaceuti ... | Kathlene Powell Linn | Option Exercise | A | 3.33 | 100,000 | 333,000 | 100,000 | ||
| Apr 13 2011 | RPTP | Raptor Pharmaceuti ... | Bruhn Suzanne Louise | Director | Option Exercise | A | 3.33 | 75,000 | 249,750 | 75,000 | |
| Apr 13 2011 | RPTP | Raptor Pharmaceuti ... | SAMANT VIJAY B | Director | Option Exercise | A | 3.33 | 75,000 | 249,750 | 75,000 | |
| Apr 13 2011 | RPTP | Raptor Pharmaceuti ... | Walbert Timothy P | Director | Option Exercise | A | 3.33 | 75,000 | 249,750 | 75,000 | |
| Jan 05 2011 | RPTP | Raptor Pharmaceuti ... | Reichenberger Marc Patrick | Option Exercise | A | 3.52 | 120,000 | 422,400 | 120,000 | ||
| Nov 23 2010 | RPTP | Raptor Pharmaceuti ... | Zankel Todd | Chief Scientific Of ... | Option Exercise | A | 3.54 | 87,345 | 309,201 | 165,526 | |
| Nov 23 2010 | RPTP | Raptor Pharmaceuti ... | STARR CHRISTOPHER M | Chief Executive Off ... | Option Exercise | A | 3.54 | 345,054 | 1,221,491 | 450,085 | |
| Nov 23 2010 | RPTP | Raptor Pharmaceuti ... | Tsuchimoto Kim R | Chief Financial Off ... | Option Exercise | A | 3.54 | 113,616 | 402,201 | 208,865 | |
| Nov 23 2010 | RPTP | Raptor Pharmaceuti ... | RIOUX PATRICE | Option Exercise | A | 3.54 | 113,616 | 402,201 | 171,897 | ||
| Nov 23 2010 | RPTP | Raptor Pharmaceuti ... | SAGER ERICH | Director | Option Exercise | A | 3.54 | 90,000 | 318,600 | 361,437 | |
| Nov 23 2010 | RPTP | Raptor Pharmaceuti ... | Keltner Llew | Director | Option Exercise | A | 3.54 | 90,000 | 318,600 | 139,968 | |
| Nov 23 2010 | RPTP | Raptor Pharmaceuti ... | FRANKLIN RICHARD L | Director | Option Exercise | A | 3.54 | 90,000 | 318,600 | 139,969 | |
| Nov 23 2010 | RPTP | Raptor Pharmaceuti ... | Daley Thomas E | Option Exercise | A | 3.54 | 113,616 | 402,201 | 190,798 | ||
| Nov 23 2010 | RPTP | Raptor Pharmaceuti ... | Anderson Raymond | Director | Option Exercise | A | 3.54 | 90,000 | 318,600 | 244,875 | |
| Oct 13 2010 | RPTP | Raptor Pharmaceuti ... | Keltner Llew | Director | Option Exercise | A | 2.97 | 30,000 | 89,100 | 79,968 | |
| Oct 13 2010 | RPTP | Raptor Pharmaceuti ... | FRANKLIN RICHARD L | Director | Option Exercise | A | 2.97 | 30,000 | 89,100 | 79,969 | |
| Oct 13 2010 | RPTP | Raptor Pharmaceuti ... | Anderson Raymond | Director | Option Exercise | A | 2.97 | 30,000 | 89,100 | 184,875 | |
| Oct 13 2010 | RPTP | Raptor Pharmaceuti ... | SAGER ERICH | Director | Option Exercise | A | 2.97 | 30,000 | 89,100 | 301,437 | |
| Oct 13 2010 | RPTP | Raptor Pharmaceuti ... | RIOUX PATRICE | Option Exercise | A | 2.97 | 56,808 | 168,720 | 115,089 | ||
| Oct 13 2010 | RPTP | Raptor Pharmaceuti ... | Daley Thomas E | Option Exercise | A | 2.97 | 56,808 | 168,720 | 133,990 | ||
| Oct 13 2010 | RPTP | Raptor Pharmaceuti ... | Tsuchimoto Kim R | Chief Financial Off ... | Option Exercise | A | 2.97 | 56,808 | 168,720 | 152,057 | |
| Oct 13 2010 | RPTP | Raptor Pharmaceuti ... | Zankel Todd | Chief Scientific Of ... | Option Exercise | A | 2.97 | 43,673 | 129,709 | 121,854 | |
| Oct 13 2010 | RPTP | Raptor Pharmaceuti ... | STARR CHRISTOPHER M | Chief Executive Off ... | Option Exercise | A | 2.97 | 172,524 | 512,396 | 277,555 | |
| Jul 09 2010 | RPTP | Raptor Pharmaceuti ... | RIOUX PATRICE | Option Exercise | A | 3.05 | 11,656 | 35,551 | 58,281 | ||
| Jul 09 2010 | RPTP | Raptor Pharmaceuti ... | Daley Thomas E | Buy | J | 0.00 | 11,656 | 0 | 104,905 | 93.2 K to 104.9 K (+12.50 %) | |
| Apr 01 2010 | RPTP | Raptor Pharmaceuti ... | RIOUX PATRICE | Option Exercise | A | 1.66 | 11,656 | 19,349 | 46,625 | ||
| Mar 12 2010 | RPTP | Raptor Pharmaceuti ... | FRANKLIN RICHARD L | Director | Option Exercise | A | 2.02 | 15,000 | 30,300 | 49,969 | |
| Mar 11 2010 | RPTP | Raptor Pharmaceuti ... | Zankel Todd | Chief Scientific Of ... | Option Exercise | A | 2.02 | 19,900 | 40,198 | 78,181 | |
| Mar 11 2010 | RPTP | Raptor Pharmaceuti ... | Anderson Raymond | Director | Option Exercise | A | 2.02 | 15,000 | 30,300 | 154,875 | |
| Mar 11 2010 | RPTP | Raptor Pharmaceuti ... | STARR CHRISTOPHER M | CEO and Director | Option Exercise | A | 2.02 | 46,750 | 94,435 | 105,031 | |
| Mar 11 2010 | RPTP | Raptor Pharmaceuti ... | Tsuchimoto Kim R | Chief Financial Off ... | Option Exercise | A | 2.02 | 18,900 | 38,178 | 95,249 | |
| Mar 11 2010 | RPTP | Raptor Pharmaceuti ... | SAGER ERICH | Director | Option Exercise | A | 2.02 | 15,000 | 30,300 | 271,437 | |
| Mar 11 2010 | RPTP | Raptor Pharmaceuti ... | Keltner Llew | Director | Option Exercise | A | 2.02 | 15,000 | 30,300 | 49,968 | |
| Mar 11 2010 | RPTP | Raptor Pharmaceuti ... | Daley Thomas E | Option Exercise | A | 2.02 | 18,900 | 38,178 | 77,182 |